Skip to main content

Eli Lilly’s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook

Eli Lilly's stock soared Tuesday toward its biggest gain in more than 20 years, following a strong earnings report and upbeat outlook for its Mounjaro drug.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.